Episode
Parky Profiles: Roger Barker, Cambridge Professor of Clinical Neuroscience
- Published
- Aug 8, 2026
- Duration seconds
- 1877
- Processing state
not_requested- Canonical source
- https://shows.acast.com/movers-and-shakers-a-podcast-about-life-with-parkinsons/episodes/6a75a02c237988582e96ca06
Actions
POST https://stenobird.com/v1/public/podcasts/movers-and-shakers-a-podcast-about-life-with-parkinson-s-6197501/episodes/parky-profiles-roger-barker-cambridge-professor-of-clinical-neuroscience/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/movers-and-shakers-a-podcast-about-life-with-parkinson-s-6197501/parky-profiles-roger-barker-cambridge-professor-of-clinical-neuroscience.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This month we’re interviewing a handful of fascinating people as part of our summer ‘Parky Profiles’ series. This week we're joined by renowned academic and researcher, Roger Barker. Roger is professor of clinical neuroscience at the University of Cambridge and a consultant neurologist at the Addenbrooke’s Hospital. Not only is our guest well known for his groundbreaking research into the use of foetal and stem cell transplants to treat Parkinson's, he is also one of the drivers and creators of the lauded World Parkinson's Congress, which we went along to in Phoenix, Arizona, earlier this year. We wanted to know how Roger came to study medicine, tackle neuroscience and become one of the UK's leading academics in the search for a Parkinson's cure. We also made sure to get his thoughts on the WPC, particularly after one controversial debate.. Movers & Shakers is brought to you in partnership with Cure Parkinson's. Presented by Rory Cellan-Jones, Gillian Lacey-Solymar, Mark Mardell, Paul Mayhew-Archer and Sir Nicholas Mostyn Produced and edited by Ewan Cameron for Podot Associate Producer: Lulu Goad Music by Alex Stobbs Hosted on Acast. See acast.com/privacy for more information.